SCHEMBL13005661

SCHEMBL13005661

CC(C)Cc1cccc(CN(CCN(C)C)Cc2ccccc2Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.45
CAMKK2 Q96RR4 1/20 0.45
TAAR1 Q96RJ0 2/20 0.43
LMNA P02545 1/20 0.40
TSHR P16473 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
AOC3 Q16853 1/20 0.38
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
RECQL P46063 1/20 0.37
HPGD P15428 1/20 0.37
PYCR1 P32322 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALOX5AP P20292 1/20 0.36
BCHE P06276 2/20 0.36
ACHE P22303 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005546 0.87 CALM1 (0.47) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13005603 0.87 CALM1 (0.44) CALM1CAMKK2TAAR1TSHRKDM4E
SCHEMBL13005713 0.86 CALM1 (0.46) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13060693 0.86 CALM1 (0.48) CALM1CAMKK2TAAR1TSHRKDM4E
SCHEMBL13005440 0.85 CALM1 (0.59) CALM1CAMKK2TAAR1LMNATSHR
SCHEMBL13005676 0.85 CALM1 (0.45) CALM1CAMKK2TAAR1TSHRKDM4E
SCHEMBL13005649 0.85 CALM1 (0.45) CALM1CAMKK2TAAR1TSHRKDM4E
SCHEMBL13005692 0.84 TSHR (0.54) CALM1CAMKK2TAAR1TSHRALDH1A1
SCHEMBL13005601 0.84 CYP2D6 (0.46) CALM1CAMKK2LMNATSHRKDM4E
SCHEMBL13005561 0.83 CALM1 (0.52) CALM1CAMKK2TSHRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed